The Pharma Legal Handbook: United Kingdom

The United Kingdom operates an independent pharmaceutical regulatory framework following its departure from the European Union, with the MHRA now acting as the sole national licensing authority. The UK has moved quickly to establish its own regulatory pathways, including the Innovative Licensing and Access Pathway (ILAP) and new international recognition procedures.

The Pharma Legal Handbook: United Kingdom provides authoritative, up-to-date guidance on pharmaceutical regulation in Great Britain and Northern Ireland. It covers MHRA product licensing and authorisation, the NICE technology appraisal process, NHS pricing and reimbursement, clinical trial requirements under post-Brexit UK law, pharmacovigilance obligations, manufacturing and GMP requirements, marketing and advertising rules, and intellectual property protection.

The post-Brexit regulatory settlement continues to evolve. This handbook reflects the current position and gives regulatory affairs, market access and legal professionals the knowledge they need to operate compliantly in the UK market.

If legal handbook content is updated, you will receive an updated PDF free for up to one year after purchase.